Iterum Therapeutics PLC Share Price & Technical Analysis
ITRM · $0.03
Healthcare / Biotechnology
$0.03
Iterum Therapeutics plc, a pharmaceutical company, develops and commercializes treatments for drug resistant bacterial infections in Ireland, Bermuda, and the United States. The company offers ORLYNVAH, an oral penem antibiotic for the treatment of uncomplicated urinary tract infections caused by Escherichia coli, Klebsiella pneumoniae, and Proteus mirabilis microorganisms in adult women with limi…
Price chart
Seasonality
May has 0 positive and 3 negative years (last 5 years shown)
-100% return in 2026, 14% avg return in past 3 years.
Swipe sideways to see all months →
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Yr | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 26 | 0% | 0% | -100% | – | – | – | – | – | – | – | – | – | -100% |
| 25 | -11% | -12% | -14% | -8% | -9% | 0% | -30% | -12% | 0% | 0% | -29% | -40% | -166% |
| 24 | -21% | -25% | 25% | -6% | 0% | -27% | 9% | 0% | -8% | 18% | 54% | -10% | 9% |
| 23 | 75% | -27% | -17% | 33% | -8% | 0% | 0% | -10% | -11% | -12% | 171% | 5% | 200% |
| 22 | -14% | 13% | -12% | -31% | -13% | -17% | 6% | -24% | -38% | 6% | -24% | -38% | -184% |
Monthly return % by calendar month · historical pattern, not a forecast
Weak · Downtrend · Neutral
Iterum Therapeutics plc, a pharmaceutical company, develops and commercializes treatments for drug resistant bacterial infections in Ireland, Bermuda, and the United States. The company offers ORLYNVAH, an oral penem antibiotic for the treatment of uncomplicated urinary tract infections caused by Escherichia coli, Klebsiella pneumoniae, and Proteus mirabilis microorganisms in adult women with limited or no alternative oral antibacterial treatment options. It is also developing sulopenem, a novel anti-infective compound with oral and intravenous formulations to treat uncomplicated urinatry tract infections, complicated urinary tract infections, and complicated intra-abdominal infections, as well as community-acquired bacterial pneumonia, acute bacterial prostatitis, gonococcal urethritis, and pelvic inflammatory diseases. Iterum Therapeutics plc was incorporated in 2015 and is headquartered in Dublin, Ireland.
Full AI Q&A, portfolio tracking, and live alerts in the app.
Key metrics
Market cap
$1.60M
P/E ratio
—
52W high
$1.42
52W low
$0.03
Volume
4,92,97,937
Beta
3.01
Related stocks in Healthcare
Merck & Co Inc Cedear (5…
₹32,900
Abbott Laboratories Cede…
₹30,500
Eli Lilly And Company Ce…
₹25,540
Unitedhealth Group Inc C…
₹17,200
₹6,600
Frequently asked questions
- What is Iterum Therapeutics PLC share price today?
- Iterum Therapeutics PLC (ITRM) last traded around $0.03 on StockPro. Prices refresh every few minutes during market hours.
- What technical signals does ITRM have?
- StockPro monitors breakouts, volume spikes, EMA reversals, and momentum for ITRM. Download the app for real-time alerts.
- How can I analyze Iterum Therapeutics PLC stock?
- Use the price chart, seasonality heatmap, key metrics, and AI insight on this page. For portfolio tracking and push alerts, download StockPro on Android or iOS.